The Huffington Post reported that in a stunning whistleblower lawsuit, the world's largest pharmaceutical company is being sued over the dangerous practice of illegally promoting a kidney transplant drug for unapproved uses -- and targeting African-Americans, even though they are at high risk of complications.

Pfizer Rapamune is a giant in the pharmaceutical industry; however, they should know that these kind of off label practices will probably cost them a lot of money in the end.

The Obama administration has been very aggressive going after companies involved in the off label promotion of drugs. There have already been a series of federal indictments and settlements related to these matters.